-
VALIDATION OF A TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) UNITED STATES (US) CLAIMS-BASED CODING ALGORITHM
Mar 18, 2026, 21:38 PM -
AN EXPLAINABLE MACHINE LEARNING ANALYSIS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) USE AND OPIOID-RELATED DIAGNOSIS RISK AMONG ADULT MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
GLOBAL BURDEN OF MULTIPLE SCLEROSIS AND FUTURE PROJECTIONS: EVIDENCE FROM GBD 2023
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA LARGE LANGUAGE MODEL ASSISTIVE SQL CODING SYSTEM
Mar 18, 2026, 21:38 PM -
VALUE-BASED DECISION BOUNDARIES ANALYSIS (VB-DBA): A NOVEL METHOD OF INTEGRATING NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING TO ESTIMATE PRICING THRESHOLDS BASED ON TARGET PRODUCT PROFILES
Mar 18, 2026, 21:38 PM -
HOW IMPROVING SCHOOL-AGED CHILDREN’S HEALTH CAN SIMULTANEOUSLY REDUCE INEQUALITY IN BOTH HEALTH AND WEALTH
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVE CKD SCREENING FOR ADULTS OVER 55 ADDRESSES MEDICAID POLICY MISALIGNMENT
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN DIET QUALITY AND CARDIOVASCULAR DISEASE MORTALITY IN CANCER SURVIVORS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY OF XANOMELINE/TROSPIUM CHLORIDE IN SCHIZOPHRENIA MANAGEMENT
Mar 18, 2026, 21:38 PM -
MULTILEVEL SOCIOECONOMIC AND REGIONAL DISPARITIES IN MATERNAL HEALTHCARE ACCESS IN A HIGH-BURDEN SETTING
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF ODEVIXIBAT AND MARALIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS)
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PATIENT-PREFERENCE-WEIGHTED SCORING ALGORITHM FOR THE QUALITY OF CARE FOR PATIENTS WITH ADVANCED ILLNESS (QCPAI) IN A MULTI-ETHNIC ASIAN SETTING
Mar 18, 2026, 21:38 PM -
ASSESSING THE PSYCHOMETRIC PROPERTIES OF TWO INSTRUMENTS MEASURING ATTITUDES TOWARDS AI AND THEIR ASSOCIATED FACTORS
Mar 18, 2026, 21:38 PM -
A REAL-WORLD EVIDENCE STUDY OF EPIGENOMIC SUBTYPING IN LIQUID BIOPSY-BASED LUNG CANCER COHORTS
Mar 18, 2026, 21:38 PM -
ARCHITECTURE OF RARE-DISEASE MODELS: STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE IN NICE HST EVALUATIONS
Mar 18, 2026, 21:38 PM -
LEVERAGING AI-DRIVEN NATURAL LANGUAGE PROCESSING TO ENHANCE SYMPTOM CAPTURE IN PRIMARY BILIARY CHOLANGITIS (PBC) AND PRIMARY SCLEROSING CHOLANGITIS (PSC)
Mar 18, 2026, 21:38 PM -
STATIN INITIATION TIME AFTER GRAVES' DISEASE DIAGNOSIS AND THE RISK OF GRAVES' ORBITOPATHY: A ONE-YEAR LANDMARK ANALYSIS
Mar 18, 2026, 21:38 PM -
PREVALENCE AND INCIDENCE OF OBESITY AND BUDGET IMPACT OF THE MOVE! WEIGHT MANAGEMENT PROGRAM IN US VETERANS
Mar 18, 2026, 21:38 PM -
USE OF NOVEL ELEMENTS OF VALUE IN COST-EFFECTIVENESS ANALYSES: INSIGHTS FROM THE CEA REGISTRY (2016-2024)
Mar 18, 2026, 21:38 PM -
ELECTRONIC HEALTH RECORDS VERSUS ADMINISTRATIVE CLAIMS TO SUPPORT PHARMACOVIGILANCE REVIEW OF SAFETY EVENTS: A FIT-FOR-PURPOSE EVALUATION
Mar 18, 2026, 21:38 PM
